Actively Recruiting
Safety and Efficacy Study of HS-10566 in High-risk Non-muscle-invasive Bladder Cancer Patients Ineligible for or Refusing Radical Cystectomy
Led by Jiangsu Hansoh Pharmaceutical Co., Ltd. · Updated on 2026-09-04
180
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating HS-10566, an intravesical gemcitabine delivery system, in patients with high-risk non-muscle-invasive bladder cancer who cannot or choose not to undergo radical cystectomy. This Phase III, open-label, multicenter study aims to assess the safety, effectiveness, tolerability, and how the drug moves through and affects the body. The study has two parts an initial dose exploration phase and a later proof-of-concept phase. During the dose exploration phase, participants receive HS-10566 placed into the bladder via a urinary catheter in treatment cycles lasting 28 days. Dosing occurs every 4 weeks for the first 24 weeks, then every 12 weeks up to 2 years or until disease progresses or treatment stops for other reasons. Each dose level is tested with 6 participants to evaluate safety and drug behavior. After establishing safe doses, one dose group advances to the proof-of-concept phase with up to 50 participants to further assess treatment effects and safety. Participants undergo regular monitoring including evaluations of tumor response, disease-free survival, and overall health for up to 36 months. Researchers collect blood and urine samples to study drug levels and effects. Safety is closely tracked through adverse event reports and clinical assessments. The entire study period can last up to 2 years of treatment with additional follow-up, allowing comprehensive observation of treatment outcomes and tolerability.
CONDITIONS
Brief Title
A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy
Research Team
Z
Zhisong HE, M.D(Doctor of Medicine)
H
Hongqian GUO, M.D(Doctor of Medicine)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here